Genetic Association of UGT۱A۱ Promoter Variants (c.-۳۲۷۹T>G and c.-۳۱۵۶G>A) with Neonatal Hyperbili-rubinemia in an Iranian Population

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 186

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IRJN-12-2_010

تاریخ نمایه سازی: 18 اردیبهشت 1400

Abstract:

Background: Several studies have reported that two promoter variants (c.-۳۲۷۹T>G and c.-۳۱۵۶G>A) in UDP-glucuronosyltransferase (UGT۱A۱) gene may contribute to neonatal hyperbilirubinemia. However, these variants have not been investigated in Iranian neonates. This cross-sectional study aimed to determine if the UGT۱A۱ promoter variants are significant risk factors associated with neonatal hyperbilirubinemia. Methods: A total of ۱۷۸ unrelated neonates, including newborns with neonatal jaundice (n=۹۵) and healthy controls (n=۸۳), were included in this study. Each individual was genotyped by the PCR-RFLP and COP-PCR at nucleotides -۳۲۷۹ and -۳۱۵۶, respectively, using fresh blood DNA. Logistic regression analyses were performed to assess the association of UGT۱A۱ promoter variants with the presence of significant hyperbilirubinemia. Anthropometric indices and clinical variables were also compared between the different genotype groups. Results: Allele and genotype analysis of the c.-۳۲۷۹T>G and c.-۳۱۵۶G>A variants showed no significant association with the risk of neonatal hyperbilirubinemia neither in the crude nor after adjustment for gestational age, gender, and birth weight in different genetic models (P>۰.۰۵). However, in haplotype-association analysis, only one haplotype (A-T) was found to be associated with the risk of neonatal hyperbilirubinemia (OR=۰.۱۹, ۹۵% CI; [۰.۱۸–۰.۲۰], P=۰.۰۰۱). Conclusion: This study failed to demonstrate that c.-۳۲۷۹T>G and c.-۳۱۵۶G>A variants alone might contribute to the risk of neonatal hyperbilirubinemia in Iranian neonates. However, the A-T haplotype may play a significant role in increasing the risk of hyperbilirubinemia.

Authors

- -

Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

- -

Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

- -

Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

- -

Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

- -

Inflammation and Inflammatory Diseases Research Centre, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

- -

Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

- -

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in neonates: types, ...
  • Fischer AF, Nakamura H, Uetani Y, Vreman HJ, Stevenson DK. ...
  • Setia S, Villaveces A, Dhillon P, Mueller BA. Neonatal jaundice ...
  • Yusoff S, Van Rostenberghe H, Yusoff NM, Talib NA, Ramli ...
  • Zhou J, Tracy TS, Remmel RP. Bilirubin glucuronidation revisited: proper ...
  • van Es HH, Bout A, Liu J, Anderson L, Duncan ...
  • Owens IS, Basu NK, Banerjee R. UDP-glucurono-syltransferases: gene structures of ...
  • Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, ...
  • Sarici SU, Saldir M. Genetic factors in neonatal hyperbilirubinemia and ...
  • 10. Costa E. Hematologically important mutations: bilirubin UDP-glucuronosyltransferase gene mutations ...
  • 11. Morioka I, Morikawa S, Yusoff S, Harahap IS, Nishimura ...
  • 12. Akaba K, Kimura T, Sasaki A, Tanabe S, Ikegami ...
  • 13. D'Silva S, Colah RB, Ghosh K, Mukherjee MB. G71R ...
  • 14. D'Silva S, Colah RB, Ghosh K, Mukherjee MB. Combined ...
  • 15. Maruo Y, Nishizawa K, Sato H, Doida Y, Shimada ...
  • 16. Maruo Y, Nishizawa K, Sato H, Sawa H, Shimada ...
  • 17. Sutomo R, Talib NA, Yusoff NM, Van Rostenberghe H, ...
  • 18. Yamamoto A, Nishio H, Waku S, Yokoyama N, Yonetani ...
  • 19. Yang H, Wang Q, Zheng L, Zheng XB, Lin ...
  • 20. Yusoff S, Takeuchi A, Ashi C, Tsukada M, Ma'amor ...
  • 21. Mehrad-Majd H, Haerian MS, Akhtari J, Ravanshad Y, Azarfar ...
  • 22. Tomerak RH, Helal NF, Shaker OG, Yousef MA. Association ...
  • 23. Ebrahim D, Gholamali M, Jalil A, Reza S, Fatemeh ...
  • 24. Kaveh M, Esmailnia T, Nayeri F, Nili F, Davari ...
  • 25. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of ...
  • 26. Boskabadi H, Ashrafzadeh F, Azarkish F, Khakshour A. Complications ...
  • 27. Gaunt TR, Rodriguez S, Day IN. Cubic exact solutions ...
  • 28. Balram C, Sabapathy K, Fei G, Khoo KS, Lee ...
  • 29. Innocenti F, Grimsley C, Das S, Ramirez J, Cheng ...
  • 30. Kaniwa N, Kurose K, Jinno H, Tanaka-Kagawa T, Saito ...
  • 31. Huang YY, Huang MJ, Yang SS, Teng HC, Huang ...
  • 32. Ki CS, Lee KA, Lee SY, Kim HJ, Cho ...
  • 33. Rooki H, Haerian MS, Azimzadeh P, Mirhafez R, Ebrahimi ...
  • نمایش کامل مراجع